6071-27-8

Basic information

• Product Name: decane-1,3-diol
• Synonyms: 1,3-decanediol
• CAS NO: 6071-27-8
• Molecular Formula: C₁₀H₂₂O₂
• Molecular Weight: 174.2805
• Mol File: 6071-27-8.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 284.9°C at 760 mmHg
• Flash Point: 129°C
• Density: 0.922g/cm³
• Vapor Pressure: 0.000333mmHg at 25°C
• Refractive Index: 1.456
• CAS DataBase Reference: decane-1,3-diol(CAS DataBase Reference)
• NIST Chemistry Reference: decane-1,3-diol(6071-27-8)
• EPA Substance Registry System: decane-1,3-diol(6071-27-8)

Safety Data

• Hazardous Substances Data: 6071-27-8(Hazardous Substances Data)

Upstream product

• 85531-69-7 2,3-epoxy-1-decanol 
• 112-30-1 1-Decanol 
• 124-13-0 Octanal 
• 78585-46-3 1-acetoxy-3-decanone 
• 111-64-8 n-octanoic acid chloride 
• 77372-60-2 1-chloro-3-decanone 
• 6071-25-6 ethyl (R/S)-3-hydroxy-decanoate 

Downstream Products

• 79727-96-1 2-[4-((E)-7-Ethoxy-3,7-dimethyl-oct-2-enyloxy)-phenyl]-2-ethyl-4-heptyl-[1,3]dioxane 

Relevant articles and documents

CYP505E3: A Novel Self-Sufficient ω-7 In-Chain Hydroxylase

The self-sufficient cytochrome P450 monooxygenase CYP505E3 from Aspergillus terreus catalyzes the regioselective in-chain hydroxylation of alkanes, fatty alcohols, and fatty acids at the ω-7 position. It is the first reported P450 to give regioselective in-chain ω-7 hydroxylation of C10–C16 n-alkanes, thereby enabling the one step biocatalytic synthesis of rare alcohols such as 5-dodecanol and 7-tetradecanol. It shows more than 70 percent regioselectivity for the eighth carbon from one methyl terminus, and displays remarkably high activity towards decane (TTN≈8000) and dodecane (TTN≈2000). CYP505E3 can be used to synthesize the high-value flavour compound δ-dodecalactone via two routes: 1) conversion of dodecanoic acid into 5-hydroxydodecanoic acid (24 percent regioselectivity), which at low pH lactonises to δ-dodecalactone, and 2) conversion of 1-dodecanol into 1,5-dodecanediol (55 percent regioselectivity), which can be converted into δ-dodecalactone by horse liver alcohol dehydrogenase.

Extracts of isochrysis sp.

The present invention relates to extracts of Isochrysis sp., preferably Tahitian Isochrysis, its cosmetic, dermatological and/or therapeutic uses and compositions and cosmetic, dermatological or therapeutic products comprising such an extract of Isochrysis sp., preferably Tahitian Isochrysis.

Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes

The present invention relates to extracts of Tetraselmis sp., preferably Tetraselmis suecica, its cosmetic, dermatological and/or therapeutic uses and compositions and cosmetic, dermatological or therapeutic products comprising such an extract of Tetraselmis sp., preferably Tetraselmis suecica.